中国社区医师
中國社區醫師
중국사구의사
Chinese Community Doctors
2015年
3期
85-85,87
,共2页
阿加曲班%急性脑梗死%神经功能缺损
阿加麯班%急性腦梗死%神經功能缺損
아가곡반%급성뇌경사%신경공능결손
Argatroban%Acute cerebral infarction%Nervous functional defect
目的：探讨阿加曲班对急性脑梗死患者的治疗效果。方法：收治急性脑梗死患者62例，随机分为A组和B组，每组31例，A组给予阿加曲班治疗，B组给予氯吡格雷，观察患者MESSS评分值和血小板聚集情况。结果：治疗后，A组和B组的血小板计数和aPPT同治疗前比较，差异没有统计学意义(P＞0.05)。两组患者不同时期的MESSS评分进行比较，A组的评分值下降幅度明显大于B组，差异具有统计学意义(P＜0.05)。结论：阿加曲班对急性脑梗死患者治疗效果明显，对人体没有不良反应，是一种安全、高效治疗急性脑梗死的药物。
目的：探討阿加麯班對急性腦梗死患者的治療效果。方法：收治急性腦梗死患者62例，隨機分為A組和B組，每組31例，A組給予阿加麯班治療，B組給予氯吡格雷，觀察患者MESSS評分值和血小闆聚集情況。結果：治療後，A組和B組的血小闆計數和aPPT同治療前比較，差異沒有統計學意義(P＞0.05)。兩組患者不同時期的MESSS評分進行比較，A組的評分值下降幅度明顯大于B組，差異具有統計學意義(P＜0.05)。結論：阿加麯班對急性腦梗死患者治療效果明顯，對人體沒有不良反應，是一種安全、高效治療急性腦梗死的藥物。
목적：탐토아가곡반대급성뇌경사환자적치료효과。방법：수치급성뇌경사환자62례，수궤분위A조화B조，매조31례，A조급여아가곡반치료，B조급여록필격뢰，관찰환자MESSS평분치화혈소판취집정황。결과：치료후，A조화B조적혈소판계수화aPPT동치료전비교，차이몰유통계학의의(P＞0.05)。량조환자불동시기적MESSS평분진행비교，A조적평분치하강폭도명현대우B조，차이구유통계학의의(P＜0.05)。결론：아가곡반대급성뇌경사환자치료효과명현，대인체몰유불량반응，시일충안전、고효치료급성뇌경사적약물。
Objective:To explore the treatment effect of argatroban on patients with acute cerebral infarction.Methods:62 patients with acute cerebral infarction were selected.They were randomly divided into A group and B group with 31 cases in each.A group was given argatroban treatment,B group was given clopidogrel.The MESSS scores and platelet aggregation of patients were observed.Results:After treatment,the blood platelet count and aPPT of A group and B group were compared with before treatment, and there was no statistically significant difference(P>0.05).MESSS in different stages of two groups were compared;the score value decreased range of A group was significantly greater than that of B group;the difference was statistically significant(P<0.05). Conclusion:Argatroban on patients with acute cerebral infarction has obvious therapeutic effect,and no adverse effects on the human body.It is safe and efficient drug in the treatment of acute cerebral infarction.
